Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases

Integr Cancer Ther
December 2009
https://pubmed.ncbi.nlm.nih.gov/20042414/

Dr Paul Anderson, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Paul Anderson shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr David Borenstein, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr David Borenstein shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Akbar Khan on Cancer, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today we're joined by Dr Akbar Khan, who works with LDN and cancer in his Medicor Cancer Centres. He has treated over 2000 patients with LDN, so we are very interested in hearing what he has to say.